Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples

Scott A Tomlins1, Daniel H Hovelson1, Jennifer M Suga2

  • 1Strata Oncology, Ann Arbor, MI.

JCO Precision Oncology
|September 3, 2021
PubMed
Summary

Tissue-based comprehensive genomic profiling (CGP) is crucial for advanced cancer treatment selection. An optimized PCR-CGP test successfully provided results for over 94% of limited tissue samples, expanding access to biomarker-guided therapies.

Related Concept Videos